Delivery Order SPE2DB20D3103-SPE2DB26FL4E7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,060.82 to AmerisourceBergen Drug Corp for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20ml vials, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued...
- The Defense Logistics Agency awarded a $5,858.87 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 10mL units. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by August 21, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,272.65 delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Xylocaine 2%-Epinephrine 1:200,000, a local anesthetic with vasoconstrictor properties commonly used in medical and surgical procedures. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $1,776.00, is for the supply of 50 milliliter bottles of Xylocaine 1% with Epinephrine 1:100,000 medication. The delivery order has a performance period ending on March 29, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20mL vials, with a ceiling value of $1,477.46. The contract was awarded on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. No set-aside designation was applied, indicating this was a competitively awarded contract. The point of performance is AmerisourceBergen Drug Corp's facility in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.13 firm fixed-price delivery order is for the supply of 4566747173 ! XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,462.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xylocaine 1%-Epi 1:100,000 50ml, a local anesthetic medication. The contract, which has a completion date of December 4, 2023, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,189.69 to AmerisourceBergen Drug Corp for Xylocaine-MPF 2% (40 mg/2 mL vials) on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded without set-aside designation under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Lidocaine 1%-Epinephrine 1:100,000 in 30ML units, with a ceiling value of $1,803.85. This is a firm fixed-price delivery order with an ultimate completion date of March 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4E7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xylocaine 1%-Epinephrine 1:100,000 in 50ML units, valued at $1,674.28. The contract, awarded on October 28, 2025, with an ultimate completion date of October 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the vendor maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen's federal contracting demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, supporting critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/28/25 |